0001209191-15-074449.txt : 20151006 0001209191-15-074449.hdr.sgml : 20151006 20151006211109 ACCESSION NUMBER: 0001209191-15-074449 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151002 FILED AS OF DATE: 20151006 DATE AS OF CHANGE: 20151006 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tracon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001394319 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8910 UNIVERSITY CENTER DRIVE STREET 2: SUITE 700 CITY: San Diego STATE: CA ZIP: 92122 BUSINESS PHONE: 858-550-0780 MAIL ADDRESS: STREET 1: 8910 UNIVERSITY CENTER DRIVE STREET 2: SUITE 700 CITY: San Diego STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Tracon Pharmaceuticals Inc DATE OF NAME CHANGE: 20070324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JAFCO Super V3 Investment Limited Partnership CENTRAL INDEX KEY: 0001590442 STATE OF INCORPORATION: M0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36818 FILM NUMBER: 151147622 BUSINESS ADDRESS: STREET 1: OTEMACHI FIRST SQUARE, WEST TOWER 11F STREET 2: 1-5-1 OTEMACHI CITY: CHIYODA-KU, TOKYO 100-0004 STATE: M0 ZIP: 100-0004 BUSINESS PHONE: 81-3-5223-7008 MAIL ADDRESS: STREET 1: OTEMACHI FIRST SQUARE, WEST TOWER 11F STREET 2: 1-5-1 OTEMACHI CITY: CHIYODA-KU, TOKYO 100-0004 STATE: M0 ZIP: 100-0004 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-10-02 0 0001394319 Tracon Pharmaceuticals, Inc. TCON 0001590442 JAFCO Super V3 Investment Limited Partnership OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI, CHIYODA-KU TOKYO M0 100-0004 JAPAN 0 0 1 0 Common Stock 2015-10-02 4 S 0 6300 10.0644 D 1537741 D Common Stock 2015-10-05 4 S 0 8800 10.0966 D 1528941 D This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $10.00 to $10.20. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $10.00 to $10.205. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. /s/ Kenji Harada 2015-10-06